Overview
Mark Huberman is an Oncologist in Boston, Massachusetts. Dr. Huberman is highly rated in 9 conditions, according to our data. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Lung Adenocarcinoma.
His clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
330 Brookline Ave Rm 913, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist in Boston, Massachusetts. Dr. Davids is highly rated in 21 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Tissue Biopsy, and Bone Marrow Transplant.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist in Boston, Massachusetts. Dr. Abramson is highly rated in 28 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Eric Jacobsen is an Oncologist in Boston, Massachusetts. Dr. Jacobsen is highly rated in 44 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Mark Huberman
How do I make an appointment with Dr. Mark Huberman?
You can book an appointment with Dr. Mark Huberman by calling their office at 617-667-9236. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Huberman a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Huberman is classified as an Distinguished expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Huberman specialize in?
While Dr. Mark Huberman is a Oncology, they have specific expertise in EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Mark Huberman participate in research or clinical trials?
Yes. Dr. Mark Huberman has published 29 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Dr. Mark Huberman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Huberman accept my insurance?
Dr. Mark Huberman accepts most major insurance plans, including Blue Cross Blue Shield. We recommend calling the office directly at 617-667-9236 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Huberman isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Huberman isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Huberman isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Huberman isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Huberman isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Huberman isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Large-Cell Lung CarcinomaDr. Huberman isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Experienced
- B-Cell LymphomaDr. Huberman isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Huberman isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Huberman isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Huberman isExperienced. Learn about Familial Colorectal Cancer.
- Follicular LymphomaDr. Huberman isExperienced. Learn about Follicular Lymphoma.
- Inflammatory Breast CancerDr. Huberman isExperienced. Learn about Inflammatory Breast Cancer.